Tech Company Financing Transactions
Metabolix Funding Round
Metabolix, operating out of Cambridge, secured $95.2 million from .
Transaction Overview
Company Name
Announced On
11/10/2006
Transaction Type
Venture Equity
Amount
$95,200,000
Round
Undisclosed
Investors
No investors have been recorded for this company.
Proceeds Purpose
The Cambridge, Mass.-based company intends to use the net proceeds of the IPO for investments in equipment for pilot manufacturing and commercial formulation of its Natural Plastic product and to fund working capital needs, personnel hires, R&D and general corporate expenses.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
21 Erie St. 100
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Overview
Metabolix (NASDAQ: MBLX) applies the cutting edge tools of biotechnology to create a new generation of highly versatile, sustainable, biobased, biodegradable, natural plastics and chemicals.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Joseph Shaulson
Chief Scientific Officer
Oliver Peoples
VP - Bus. Development
Max Senechal
VP - General Counsel
Sarah Cecil
VP - Manufacturing
Lynne Brum
VP - Manufacturing
Johan Walsem
Browse more venture capital transactions:
Prev: 11/10/2006: Transcend Medical venture capital transaction
Next: 11/10/2006: Photobucket venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. All VC database entries reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs